Oxford BioMedica
| Use attributes for filter ! | |
| Stock price | OXB |
|---|---|
| Disclaimer | |
| Ceo | John Dawson |
| Revenue | 15. 9 million GBP (May 2016) |
| Founded | 1995 |
| Headquarters | Oxford |
| United Kingdom | |
| Founders | Alan Kingsman |
| Susan Kingsman | |
| Subsidiaries | Oxxon Therapeutics Limited |
| Oxford Biomedica (UK) Limited | |
| Biomedica Inc. | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2349851 |
About Oxford BioMedica
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It was established in 1995 as a spin out from Oxford University. The Company's development pipeline includes investigational treatments for cancer, Parkinson's disease and retinopathy.
